Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126914261 | 12691426 | 1 | I | 20160818 | 20160826 | 20160826 | EXP | CA-PFIZER INC-2016403961 | PFIZER | 0.00 | F | Y | 0.00000 | 20160826 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126914261 | 12691426 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | U | 0 | 50 | MG | /wk | ||||||
| 126914261 | 12691426 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 20 MG, WEEKLY | U | 11719 | 20 | MG | /wk | ||||||
| 126914261 | 12691426 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 126914261 | 12691426 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
| 126914261 | 12691426 | 5 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 40 MG, 2X/WEEK | U | 0 | 40 | MG | BIW | ||||||
| 126914261 | 12691426 | 6 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, DAILY | U | 0 | 20 | MG | TABLET | ||||||
| 126914261 | 12691426 | 7 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, 4X/DAY | U | 0 | 750 | MG | QID | ||||||
| 126914261 | 12691426 | 8 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 5 MG/KG, ONCE EVERY 8 WEEKS | U | 0 | 5 | MG/KG | |||||||
| 126914261 | 12691426 | 9 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126914261 | 12691426 | 10 | C | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126914261 | 12691426 | 1 | Rheumatoid arthritis |
| 126914261 | 12691426 | 2 | Rheumatoid arthritis |
| 126914261 | 12691426 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126914261 | 12691426 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126914261 | 12691426 | Arthropathy | |
| 126914261 | 12691426 | Drug ineffective | |
| 126914261 | 12691426 | Gait disturbance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |